drugset / Trial / NCT07040046
HS-10542 Study in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, dose escalation phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, and the food effect on the pharmacokinetics of HS-10542 in healthy participants.
Timeline
- Start
- 2025-05-16
- Primary completion
- 2025-12-04
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10542 | Small molecule | — | Oral |
Indications
No indication recorded.